Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate

By Fukasawa L.O.   Gorla M.C.O.   Schenkman R.P.F.   Garcia L.R.   Carneiro S.M.   Raw I.   Tanizaki M.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2951-2958

Elsevier

Access to resources Recommend Favorite

Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin

By Christodoulides M.   Rattue E.   Heckels J.E.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 131-139

Elsevier

Access to resources Recommend Favorite

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

By Holst J.   Feiring B.   Fuglesang J.E.   Hoiby E.A.   Nokleby H.   Aaberge I.S.   Rosenqvist E.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 734-737

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults

By Richmond P.   Goldblatt D.   Fusco P.C.   Fusco J.D.S.   Heron I.   Clark S.   Borrow R.   Michon F.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 641-646

Elsevier

Access to resources Recommend Favorite

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease

By Fischer M.   Carlone G.M.   Holst J.   Williams D.   Stephens D.S.   Perkins B.A.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2377-2383

Elsevier

Access to resources Recommend Favorite